Evaluation and management of heart rhythm disturbances due to cardiac sarcoidosis

Heart Lung and Circulation

Volumn 23, Issue 12, 2014, Pages 1100-1109

  Selan, Jeffrey C ^a   Michaelson, Melody ^b   Fanburg, Barry L ^a   Estes, N A Mark ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrhythmia; Cardiac conduction disease; Cardiac sarcoidosis; Corticosteroids; Electrophysiology; Implantable cardioverter defibrillator (ICD)

Indexed keywords

ANTIARRHYTHMIC AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLUCOCORTICOID; METHOTREXATE; PREDNISONE;

CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CATHETER ABLATION; CLINICAL FEATURE; COMPLETE HEART BLOCK; CONGESTIVE HEART FAILURE; CORTICOSTEROID THERAPY; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT BUNDLE BRANCH BLOCK; HEART RIGHT VENTRICLE DYSPLASIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART TRANSPLANTATION; HEART VENTRICLE ANEURYSM; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE SIZE; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT VENTRICULAR END DIASTOLIC DIAMETER; LOW DRUG DOSE; MEDICAL HISTORY; NEW YORK HEART ASSOCIATION CLASS; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; SARCOIDOSIS; SUDDEN CARDIAC DEATH; SURVIVAL RATE; TIME TO TREATMENT; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; ARRHYTHMIAS, CARDIAC; ARTIFICIAL HEART PACEMAKER; CARDIOMYOPATHIES; HEART MUSCLE CONDUCTION SYSTEM; HEART RATE; PATHOPHYSIOLOGY;

ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; GLUCOCORTICOIDS; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; PACEMAKER, ARTIFICIAL; SARCOIDOSIS;

EID: 84912562141     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2014.07.065     Document Type: Review

References (55)

1. Hutchinson J. Cases of Mortimer's Malady. Arch Surg 1898, 307.
2. Boeck C. Multiple Benign Sarcoid of the Skin. J Cutan Genitourin Dis 1899, 543.
3. Bernstein M., Konzlemann F., Sidlick D. Boeck's sarcoid: report of a case with visceral involvement. Arch Intern Med 1929, 721-734.
4. Longcope W., Freiman D. A study of sarcoidosis: based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore) 1952, 1-132.
5. Birnie D.H., Sauer W.H., Bogun F., Cooper J.M., Culver D.A., Duvernoy C.S., et al. HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis. Heart Rhythm 2014.
6. Uusimaa P., Ylitalo K., Anttonen O., Kerola T., Virtanen V., Pääkkö E., et al. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace 2008, 10:760-766.
7. Banba K., Kusano K.F., Nakamura K., Morita H., Ogawa A., Ohtsuka F., et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm 2007, 4:1292-1299.
8. Bargout R., Kelly R.F. Sarcoid heart disease: clinical course and treatment. Int J Cardiol 2004, 97:173-182.
9. Viles-Gonzalez J.F., Pastori L., Fischer A., Wisnivesky J.P., Goldman M.G., Mehta D. Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications. Chest 2013, 143:1085-1090.
10. Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disord 2007, 89-102.
11. Hillerdal G., Nöu E., Osterman K., Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984, 130:29-32.
12. Rybicki B.A., Major M., Popovich J., Maliarik M.J., Iannuzzi M.C. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997, 145:234-241.
13. Doughan A.R., Williams B.R. Cardiac sarcoidosis. Heart 2006, 92:282-288.
14. Schoppet M., Pankuweit S., Maisch B. Cardiac sarcoidosis: cytokine patterns in the course of the disease. Arch Pathol Lab Med 2003, 127:1207-1210.
15. Nery P.B., Beanlands R.S., Nair G.M., Green M., Yang J., McArdle B.A., et al. Atrioventricular Block as the Initial Manifestation of Cardiac Sarcoidosis in Middle-Aged Adults. J Cardiovasc Electrophysiol 2014.
16. Kandolin R., Lehtonen J., Kupari M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 2011, 4:303-309.
17. Schuller J.L., Olson M.D., Zipse M.M., Schneider P.M., Aleong R.G., Wienberger H.D., et al. Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement. J Cardiovasc Electrophysiol 2011, 22:1243-1248.
18. Morales A.R., Levy S., Davis J., Fine G. Sarcoidosis and the heart. Pathol Annu 1974, 9:139-155.
19. Abeler V. Sarcoidosis of the cardiac conducting system. Am Heart J 1979, 97:701-707.
20. Wilkins C.E., Barron T., Lowrimore M.G., Massumkhani G.A., Klima T., Younis A.C., et al. Cardiac sarcoidosis: two cases with ventricular tachycardia and review of cardiac involvement in sarcoid. Tex Heart Inst J 1985, 12:377-383.
21. Jefic D., Joel B., Good E., Morady F., Rosman H., Knight B., et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhythm 2009, 6:189-195.
22. Nery P.B., Mc Ardle B.A., Redpath C.J., Leung E., Lemery R., Dekemp R., et al. Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Pacing Clin Electrophysiol 2014, 37:364-374.
23. Betensky B.P., Tschabrunn C.M., Zado E.S., Goldberg L.R., Marchlinski F.E., Garcia F.C., et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm 2012, 9:884-891.
24. Naruse Y., Sekiguchi Y., Nogami A., Okada H., Yamauchi Y., Machino T., et al. A Systematic Treatment Approach to Ventricular Tachycardia in Cardiac Sarcoidosis. Circ Arrhythm Electrophysiol 2014.
25. Koplan B.A., Soejima K., Baughman K., Epstein L.M., Stevenson W.G. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm 2006, 3:924-929.
26. Kawamura Y., Yoshida A., Toyoshima E., Sato N., Kawashima E., Hasebe N., et al. A case of cardiac sarcoidosis: significance of ventricular tachycardia originating from the septum. Jpn Circ J 1998, 62:458-461.
27. Stees C.S., Khoo M.S.C., Lowery C.M., Sauer W.H. Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis. J Cardiovasc Electrophysiol 2011, 22:210-213.
28. Tavora F., Cresswell N., Li L., Ripple M., Solomon C., Burke A. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiol 2009, 104:571-577.
29. Hiraga H., Yuwai K., Hiroe M., Al E. Guidelines for the diagnosis of cardiac sarcoidosis: Study Report of Diffuse Pulmonary Diseases. Japanese Minist Heal Welf 1993, 23.
30. Dechering D.G., Kochhäuser S., Wasmer K., Zellerhoff S., Pott C., Köbe J., et al. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm 2013, 10:158-164.
31. Vasaiwala S.C., Finn C., Delpriore J., Leya F., Gagermeier J., Akar J.G., et al. Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 2009, 20:473-476.
32. Mehta D., Lubitz S.A., Frankel Z., Wisnivesky J.P., Einstein A.J., Goldman M., et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 2008, 133:1426-1435.
33. Suzuki T., Kanda T., Kubota S., Imai S., Murata K. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest 1994, 106:1021-1024.
34. Santucci P.A., Morton J.B., Picken M.M., Wilber D.J. Electroanatomic mapping of the right ventricle in a patient with a giant epsilon wave, ventricular tachycardia, and cardiac sarcoidosis. J Cardiovasc Electrophysiol 2004, 15:1091-1094.
35. Uyarel H., Uslu N., Okmen E., Tartan Z., Kasikcioglu H., Dayi S.U., et al. QT dispersion in sarcoidosis. Chest 2005, 128:2619-2625.
36. Schuller J.L., Lowery C.M., Zipse M., Aleong R.G., Varosy P.D., Weinberger H.D., et al. Diagnostic utility of signal-averaged electrocardiography for detection of cardiac sarcoidosis. Ann Noninvasive Electrocardiol 2011, 16:70-76.
37. Freeman A.M., Curran-Everett D., Weinberger H.D., Fenster B.E., Buckner J.K., Gottschall E.B., et al. Predictors of cardiac sarcoidosis using commonly available cardiac studies. Am J Cardiol 2013, 112:280-285.
38. Curimbaba J., Rodrigues S.C.S., Moreira J.M., Silva LÂA, Pereira C.A., de C., Pimenta J. Cardiac electrophysiological assessment in patients with sarcoidosis. Arq Bras Cardiol 2011, 96:266-271.
39. Kim J.S., Judson M.A., Donnino R., Gold M., Cooper L.T., Prystowsky E.N., et al. Cardiac sarcoidosis. Am Heart J 2009, 157:9-21.
40. Ohira H., Tsujino I., Ishimaru S., Oyama N., Takei T., Tsukamoto E., et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 2008, 35:933-941.
41. Youssef G., Leung E., Mylonas I., Nery P., Williams K., Wisenberg G., et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med 2012, 53:241-248.
42. Aizer A., Stern E.H., Gomes J.A., Teirstein A.S., Eckart R.E., Mehta D. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol 2005, 96:276-282.
43. Yazaki Y., Isobe M., Hiroe M., Morimoto S., Hiramitsu S., Nakano T., et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001, 88:1006-1010.
44. Belhassen B., Pines A., Laniado S. Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis. Chest 1989, 95:918-920.
45. Thachil A., Christopher J., Sastry B.K.S., Reddy K.N., Tourani V.K., Hassan A., et al. Monomorphic ventricular tachycardia and mediastinal adenopathy due to granulomatous infiltration in patients with preserved ventricular function. J Am Coll Cardiol 2011, 58:48-55.
46. Stein E., Stimmel B., Siltzbach L.E. Clinical course of cardiac sarcoidosis. Ann N Y Acad Sci 1976, 278:470-474.
47. Kron J., Sauer W., Schuller J., Bogun F., Crawford T., Sarsam S., et al. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace 2013, 15:347-354.
48. Epstein A.E., Dimarco J.P., Ellenbogen K.A., Estes N.A.M., Freedman R.A., Gettes L.S., et al. ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm 2008, 5:934-955.
49. Epstein A.E., DiMarco J.P., Ellenbogen K.A., Estes N.A.M., Freedman R.A., Gettes L.S., et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guide. Circulation 2013, 127:e283-e352.
50. Schuller J.L., Lowery C.M., Weinberger H.D., Sauer W.H. Fluctuation in ventricular sensing leading to underdetection of ventricular fibrillation in a patient with cardiac sarcoidosis. J Interv Card Electrophysiol 2011, 30:81-85.
51. Zaidi A.R., Zaidi A., Vaitkus P.T. Outcome of heart transplantation in patients with sarcoid cardiomyopathy. J Heart Lung Transplant 2007, 26:714-717.
52. Okamoto H., Mizuno K., Ohtoshi E. Cutaneous sarcoidosis with cardiac involvement. Eur J Dermatol 1999, 9:466-469.
53. Kato Y., Morimoto S., Uemura A., Hiramitsu S., Ito T., Hishida H. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis 2003, 20:133-137.
54. Chapelon-Abric C., de Zuttere D., Duhaut P., Veyssier P., Wechsler B., Huong D.L.T., et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 2004, 83:315-334.
55. Yodogawa K., Seino Y., Ohara T., Takayama H., Katoh T., Mizuno K. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol 2011, 16:140-147.